Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced plans to open a new Customer Experience Centre in Düsseldorf, Germany by summer 2026, aimed at serving the EMEA (Europe, Middle East and Africa) region. The facility will feature a state-of-the-art Demonstration Laboratory showcasing the company's complete instrument portfolio.

Key highlights include the newly launched Leo™ System with Simple Western™ Technology for automated western blot assays, and the COMET™ spatial biology platform for automated, high-throughput tissue profiling. The center will complement Bio-Techne's existing UK facility, allowing for expanded customer demonstrations and hands-on experience with their instruments.

The strategic location in Düsseldorf was selected for its vibrant life sciences sector and proximity to the Benelux region, facilitating access to multiple European markets. This expansion will enable Bio-Techne to grow its customer-facing team in EMEA and support long-term regional growth, particularly in the German market.

Positive

• Strategic expansion into key European market with new demonstration facility
• Potential for increased market penetration in EMEA region
• Enhanced customer support and demonstration capabilities

Negative

• None.

MINNEAPOLIS, March 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region and support the company's long-term regional growth strategy.

The new Customer Experience Centre is scheduled to open in summer 2026 and will feature a state-of-the-art Demonstration Laboratory hosting Bio-Techne's full instrument portfolio, including:

• The recently launched Leo™ System, powered by Simple Western™ Technology, which offers the throughput and precision of standard ELISAs in a fully automated western blot assay, expanding applications in bioanalytical workflows from discovery through commercialization.
• The best-in-class spatial biology platform, COMET™, which is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities.

"Our new Customer Experience Centre will complement our existing Demonstration Laboratory in the UK, enabling us to provide more customers with hands-on experience of our unique instrument portfolio, and demonstrate how our solutions can accelerate their cutting-edge science and bring next generation therapies to market faster," said Dr. Peter Schuessler, Vice President, EMEA, Bio-Techne.

The facility's capacity will enable Bio-Techne to grow its customer-facing team in EMEA and support long-term regional growth, including in the large German market.

Düsseldorf was carefully chosen as the site for this new centre due to its thriving life sciences sector and strategic proximity to the Benelux region, providing seamless access to customers from multiple European markets.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit http://www.bio-techne.com or follow the Company on social media at Facebook, LinkedIn, Twitter or YouTube.

About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com 
612-656-4416

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-new-customer-experience-centre-in-dusseldorf-germany-302409810.html

SOURCE Bio-Techne Corporation

FAQ

When will Bio-Techne (TECH) open its new Customer Experience Centre in Düsseldorf?

Bio-Techne's new Customer Experience Centre in Düsseldorf is scheduled to open in summer 2026.

What key instruments will Bio-Techne (TECH) showcase at the Düsseldorf facility?

The facility will showcase the Leo™ System for automated western blot assays and the COMET™ spatial biology platform for tissue profiling.

Why did Bio-Techne (TECH) choose Düsseldorf for its new Customer Experience Centre?

Düsseldorf was chosen for its thriving life sciences sector and strategic proximity to the Benelux region, providing easy access to multiple European markets.

How will the new Düsseldorf facility impact Bio-Techne's (TECH) EMEA operations?

The facility will enable Bio-Techne to expand its customer-facing team and support long-term regional growth, particularly in the German market.